By automating monitoring processes, AI can revolutionise quality assurance and regulatory compliance by automating monitoring processes to ensure adherence to stringent industry standards.
AI systems can analyse manufacturing data in real-time to detect anomalies or deviations from standard protocols, facilitating prompt corrective actions and maintaining high product quality.
AI can also optimise inventory management and distribution channels by predicting demand fluctuations and identifying efficiencies to reduce waste and operational costs.
AI-driven models can sift through complex genetic data to identify mutations and variations linked to diseases, as well simulate the effects of different compounds, which help researchers develop targeted therapies and dramatically reduce the time and cost of discovering new drugs.
Digital twins - virtual replicas of physical assets - can simulate, monitor and optimise drug manufacturing and clinical development in real-time, improving decision making and reducing costly errors.